About pcm

Manuscript Submission

AME Editing Service

Reprint & Permission

Advertising

Contact us

PCM Chinese Edition more

早期三阴性乳腺癌免疫检查点抑制剂回顾

三阴性乳腺癌(triple negative breast... More >>

人类肿瘤中BRAF改变的叙述性综述:诊断和预测意义

B-Raf原癌基因,丝氨酸/苏氨酸激酶( BRAF... More >>

营养影响疾病的潜在分子机制

人体约有50至70万亿个细胞,每个细胞都在高度复杂的生物系统网络中发挥... More >>
Editorial Commentary 
Uncommon EGFR mutations in non-small-cell lung cancer
Marco Russano, Giuseppe Perrone, Giuseppina Rita Di Fazio, Alessandro Galletti, Fabrizio Citarella, Valentina Santo, Leonardo Brunetti, Alessia Vendittelli, Bruno Vincenzi, Giuseppe Tonini, Daniele Santini
Precision Cancer Medicine  
2022;
5:
30  
Case Report 
Giant perivascular spaces in brain: case report with a comprehensive literature review
Gaurav Cheraya, Suryansh Bajaj, Salil Sharma, Darshan Gandhi, Jignesh Shah, Nisarg Parikh, Nishant Gupta
Precision Cancer Medicine  
2022;
5:
29  
Case Report 
Sporadic mesenteric desmoid-type fibromatosis with “double-hit” T41A and S45P beta-catenin mutation profile: a case report of an extremely rare event—clinically relevant or much ado about nothing?
Saba Shafi, Ashley Patton, Alan Rogers, Valerie Grignol, Steve Oghumu, O. Hans Iwenofu
Precision Cancer Medicine  
2022;
5:
28  
Review Article 
Moving through rare lung cancer histologies: a narrative review on diagnosis and treatment of selected infrequent entities
Chiara Pisano, Gianluca Witel, Marco De Filippis, Angela Listì, Francesca Napoli, Luisella Righi, Silvia Novello, Paolo Bironzo
Precision Cancer Medicine  
2022;
5:
27  
Review Article 
Review: biological implications of oncogenic rearrangements in non-small cell lung cancer
Maria Vittoria Di Marco, Claudia Voena
Precision Cancer Medicine  
2022;
5:
26  
Review Article 
Current state of the art on the diagnosis and the role of target therapy for treatment of ROS1-rearranged non-small cell lung cancer: a narrative review
Francesca Parisi, Giovanni Rossi, Federica Biello, Marco Tagliamento, Giulia Barletta, Lodovica Zullo, Eugenia Cella, Gianluca Sacco, Chiara Dellepiane, Elisa Bennicelli, Diletta Favero, Angela Alama, Simona Coco, Silvia Marconi, Linda Zinoli, Enrica Teresa Tanda, Paolo Pronzato, Erika Rijavec, Carlo Genova
Precision Cancer Medicine  
2022;
5:
25  
Review Article 
Clinical implications of liquid biopsies in urogenital tumors: a narrative review
Laudy Chehade, Ali H. Abdel Sater, Hampig Raphael Kourie, Deborah Mukherji, Ali Shamseddine
Precision Cancer Medicine  
2022;
5:
24  
Review Article 
A narrative review of epidemiology and prevention of lung cancer: sex/gender differences?
Sandra Baldacci, Sara Maio, Claudia Meschi, Davide Chimera, Sofia Tagliaferro, Anna Antonietta Angino, Patrizia Silvi, Francesco Pistelli, Laura Carrozzi
Precision Cancer Medicine  
2022;
5:
23  
Editorial 
Lung cancer in women
Editta Baldini
Precision Cancer Medicine  
2022;
5:
22  
Editorial 
How should clinicians manage metastatic non-small cell lung cancer patients with BRAF non-V600E mutations?
Edyta Maria Urbanska
Precision Cancer Medicine  
2022;
5:
21  
Case Report 
RET-mutated non-small cell lung cancer treated with pralsetinib: a case series
Alessandro Galletti, Marco Russano, Fabrizio Citarella, Giuseppina Di Fazio, Valentina Santo, Leonardo Brunetti, Bruno Vincenzi, Giuseppe Tonini, Daniele Santini
Precision Cancer Medicine  
2022;
5:
20  
Case Report 
Ineffective target therapy in non-small cell lung cancer harboring BRAF G466R mutation: a case report and biological rationale
Fabrizio Citarella, Marco Russano, Giuseppe Perrone, Giuseppina-Rita Di Fazio, Raffaele Giusti, Bruno Vincenzi, Giuseppe Tonini, Daniele Santini
Precision Cancer Medicine  
2022;
5:
19  
Case Report 
KRAS G12V mutation as an acquired resistance mechanism after treatment with dabrafenib and trametinib in non-small cell lung cancer harbouring the BRAF V600E mutation: a case report
Hajime Oi, Kiyotaka Yoh, Shingo Matsumoto, Hiroki Izumi, Yuji Shibata, Tetsuya Sakai, Kaname Nosaki, Yoshitaka Zenke, Koichi Goto
Precision Cancer Medicine  
2022;
5:
18  
Review Article 
Current evidence of BRCA mutations in genitourinary and gynecologic tumors: a scoping review
Alain Chebly, Tony Yammine, Elie Rassy, Stergios Boussios, Michele Moschetta, Chantal Farra
Precision Cancer Medicine  
2022;
5:
17  
Review Article 
The role of digital and integrative pathology for the detection of translocations: a narrative review
Carlo Beretta, Stefano Ceola, Fabio Pagni, Vincenzo L’Imperio
Precision Cancer Medicine  
2022;
5:
16  
Review Article 
Drug-related toxicity in breast cancer patients: a new path towards tailored treatment?—a narrative review
Eleonora Lai, Mara Persano, Marco Dubois, Dario Spanu, Clelia Donisi, Marta Pozzari, Giulia Deias, Giorgio Saba, Marco Migliari, Nicole Liscia, Mariele Dessì, Mario Scartozzi, Francesco Atzori
Precision Cancer Medicine  
2022;
5:
15  
Review Article 
The past, present, and future of non-metastatic castration-resistant prostate cancer (nmCRPC): a narrative review
Natalia Vidal, Juan Gómez Rivas, Laura Fernández, Jesús Moreno, Javier Puente
Precision Cancer Medicine  
2022;
5:
14  
Review Article 
A narrative review of the management of BRAF non-V600E mutated metastatic non-small cell lung cancer
Inas Abuali, Chung-Shien Lee, Nagashree Seetharamu
Precision Cancer Medicine  
2022;
5:
13  
Original Article 
Prospective and single-blinded evaluation of the multi-cancer Carcimun-test
Andreas Salat, Wieland Voigt, Berthold von und zu Zwerger
Precision Cancer Medicine  
2022;
5:
12  
Editorial 
From icing to slicing the cake: the new hope of precision medicine for lung cancer
Giuseppe L. Banna, Alfredo Addeo
Precision Cancer Medicine  
2022;
5:
11  

Editorial

AR-V7 and treatment selection in advanced prostate cancer: are we there yet?
Diogo A. Bastos, Emmanuel S. Antonarakis

Case Report: Precision Oncology Tumor Board

Cases of ROS1-rearranged lung cancer: when to use crizotinib, entrectinib, lorlatinib, and beyond?
Kartik Sehgal, Andrew J. Piper-Vallillo, Hollis Viray, Adeel M. Khan, Deepa Rangachari, Daniel B. Costa